A comparison of the location in membranes of curcumin and curcumin-derived bivalent compounds with potential neuroprotective capacity for Alzheimer’s disease
Source abstract
Abstract
Curcumin and two bivalent compounds, namely 17MD and 21MO, both obtained by conjugation of curcumin with a steroid molecule that acts as a membrane anchor, were comparatively studied. When incorporated into 1,2-dipalmitoyl-sn-glycero-3-phosphocholine the compounds showed a very limited solubility in the model membranes. Curcumin and the two bivalent compounds were also incorporated in membranes of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and quenching the fluorescence of pure curcumin or of the curcumin moiety in the bivalent compounds by acrylamide it was seen that curcumin was accessible to this water soluble quencher but the molecule was somehow located in a hydrophobic environment. This was confirmed by quenching with doxyl-phosphatidylcholines, indicating that the curcumin moieties of 17MD and 21MO were in a more polar environment than pure curcumin itself. 1H NOESY MAS-NMR analysis supports this notion by showing that the orientation of curcumin was parallel to the plane of the membrane surface close to C2 and C3 of the fatty acyl chains, while the curcumin moiety of 17MD and 21MO positioned close to the polar part of the membrane with the steroid moiety in the centre of the membrane. Molecular dynamics studies were in close agreement with the experimental results with respect to the likely proximity of the protons studied by NMR and show that 17MD and 21MO have a clear tendency to aggregate in a fluid membrane. The anchorage of the bivalent compounds to the membrane leaving the curcumin moiety near the polar part may be very important to facilitate the bioactivity of the curcumin moiety when used as anti-Alzheimer drugs.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Lipid Membrane Structure and Behavior · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (72)
Show source-provided references
1. Curcumin, a component of golden spice: from bedside to bench and back10.1016/j.biotechadv.2014.04.004 ↗
2. Curcumin and curcuminoids in quest for medicinal status10.18388/abp.2012_2139 ↗
3. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases10.1111/bph.13621 ↗
4. Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression10.1007/s10529-013-1173-y ↗
5. Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells10.1016/j.foodchem.2013.02.016 ↗
6. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma10.2174/157340607781745447 ↗
7. Curcumin is a potent modulator of microglial gene expression and migration10.1186/1742-2094-8-125 ↗
8. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit10.1111/j.1471-4159.2009.05908.x ↗
9. Curcumin inhibits gastric inflammation induced by Helicobacter pylori infection in a mouse model10.3390/nu7010306 ↗
10. Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro10.1002/jnr.20025 ↗
11. Curcumin affords neuroprotection and inhibits alpha-synuclein aggregation in lipopolysaccharide-induced Parkinson’s disease model10.1007/s10787-017-0402-8 ↗
12. Apoptosis-independent alterations in membrane dynamics induced by curcumin10.1006/excr.1998.4225 ↗
13. Membrane-thinning effect of curcumin10.1529/biophysj.107.126888 ↗
14. The bound states of amphipathic drugs in lipid bilayers: study of curcumin10.1529/biophysj.108.133736 ↗
15. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin10.1021/ja809217u ↗
16. Curcumin disorders 1,2-dipalmitoyl-sn-glycero-3-phosphocholine membranes and favors the formation of nonlamellar structures by 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine10.1021/jp101045p ↗
17. Modulation of raft domains in a lipid bilayer by boundary-active curcumin10.1039/c3cc47738j ↗
18. Interaction of curcumin with lipid monolayers and liposomal bilayers, Colloids and surfaces10.1016/j.colsurfb.2011.06.037 ↗
19. Study of curcumin behavior in two different lipid bilayer models of liposomal curcumin using molecular dynamics simulation10.1080/07391102.2015.1030692 ↗
20. Curcumin protects membranes through a carpet or insertion model depending on hydration10.1021/acs.langmuir.7b01562 ↗
21. Influence of a curcumin derivative on hIAPP aggregation in the absence and presence of lipid membranes10.1039/C5CC07792C ↗
22. Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-β species10.1073/pnas.1220326110 ↗
23. Structural characterization and inhibition of toxic amyloid-beta oligomeric intermediates10.1016/j.bpj.2013.05.004 ↗
24. Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity10.1073/pnas.1006091107 ↗
25. Misfolded proteins in Alzheimer’s disease and type II diabetes10.1039/C1CS15112F ↗
26. Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer’s Disease10.1021/acs.jmedchem.7b01284 ↗
27. Development of bivalent compounds as potential neuroprotectants for Alzheimer’s disease10.1016/j.bmcl.2019.05.035 ↗
28. Mechanistic Insight of Bivalent Compound 21MO as Potential Neuroprotectant for Alzheimer’s Disease10.3390/molecules21040412 ↗
29. Bivalent ligands incorporating curcumin and diosgenin as multifunctional compounds against Alzheimer’s disease10.1016/j.bmc.2015.10.032 ↗
30. Bivalent Compound 17MN Exerts Neuroprotection through Interaction at Multiple Sites in a Cellular Model of Alzheimer’s Disease10.3233/JAD-150242 ↗
31. Bivalent ligand containing curcumin and cholesterol as fluorescence probe for Abeta plaques in Alzheimer’s disease10.1021/cn200122j ↗
32. Bivalent ligands targeting multiple pathological factors involved in Alzheimer’s disease10.1021/ml300229y ↗
33. Clicked" bivalent ligands containing curcumin and cholesterol as multifunctional abeta oligomerization inhibitors: design, synthesis, and biological characterization10.1021/jm100601q ↗
34. Lakowicz · 2007
35. Phenolic group of alpha-tocopherol anchors at the lipid-water interface of fully saturated membranes10.1021/acs.langmuir.7b04142 ↗
36. Localization of multidrug transporter substrates within model membranes10.1021/bi0524870 ↗
37. Schrödinger · 2015
38. Abraham · 2015
39. Definition and testing of the GROMOS force-field versions 54A7 and 54B710.1007/s00249-011-0700-9 ↗
40. On the validation of molecular dynamics simulations of saturated and cis-monounsaturated phosphatidylcholine lipid bilayers: a comparison with experiment10.1021/ct900487a ↗
41. A new force field for simulating phosphatidylcholine bilayers10.1002/jcc.21396 ↗
42. An automated force field topology builder (ATB) and repository: version 1.010.1021/ct200196m ↗
43. Testing and validation of the Automated Topology Builder (ATB) version 2.0: prediction of hydration free enthalpies10.1007/s10822-014-9713-7 ↗
44. PACKMOL: a package for building initial configurations for molecular dynamics simulations10.1002/jcc.21224 ↗
45. Canonical sampling through velocity rescaling10.1063/1.2408420 ↗
46. Molecular dynamics with coupling to an external bath10.1063/1.448118 ↗
47. Particle mesh ewald: an N•log(N) method for ewald sums in large systems10.1063/1.464397 ↗
48. LINCS: A Linear Constraint Solver for Molecular Simulations10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H ↗
49. Polymorphic transitions in single crystals: a new molecular dynamics method10.1063/1.328693 ↗
50. Fluorescence quenching of indole and model micelle systems10.1021/j100546a014 ↗
51. Methods and applications of site-directed spin labeling EPR spectroscopy10.1016/S0091-679X(07)84020-9 ↗
52. Parallax method for direct measurement of membrane penetration depth utilizing fluorescence quenching by spin-labeled phospholipids10.1021/bi00375a006 ↗
53. Analysis of protein and peptide penetration into membranes by depth-dependent fluorescence quenching: theoretical considerations10.1016/S0006-3495(99)77258-9 ↗
54. Conformation of the C-terminal domain of the pro-apoptotic protein Bax and mutants and its interaction with membranes10.1021/bi010667d ↗
55. The vertical location of alpha-tocopherol in phosphatidylcholine membranes is not altered as a function of the degree of unsaturation of the fatty acyl chains10.1039/C6CP08872D ↗
56. Investigation of lipid organization in biological membranes by two-dimensional nuclear overhauser enhancement spectroscopy10.1021/jp983428h ↗
57. Molecular dynamics simulations of lipid bilayers10.1016/S1359-0294(00)00058-3 ↗
58. Anticancer agent edelfosine exhibits a high affinity for cholesterol and disorganizes liquid-ordered membrane structures10.1021/acs.langmuir.8b01539 ↗
59. Effect of a dirhamnolipid biosurfactant on the structure and phase behaviour of dimyristoylphosphatidylserine model membranes10.1016/j.colsurfb.2019.110576 ↗
60. Interpretation of NOESY cross-relaxation rates from molecular dynamics simulation of a lipid bilayer10.1021/ja991456n ↗
61. Semi-classical nuclear spin relaxation theory revisited for use with biological macromolecules10.1016/S0079-6565(01)00043-7 ↗
62. Structure of fully hydrated fluid phase lipid bilayers with monounsaturated chains10.1007/s00232-005-7006-8 ↗
63. Area per lipid and cholesterol interactions in membranes from separated local-field (13)C NMR spectroscopy10.1016/j.bpj.2014.07.044 ↗
64. Effect of NaCl and KCl on phosphatidylcholine and phosphatidylethanolamine lipid membranes: insight from atomic-scale simulations for understanding salt-induced effects in the plasma membrane10.1021/jp0750708 ↗
65. Structure, dynamics, and hydration of POPC/POPS bilayers suspended in NaCl, KCl, and CsCl solutions10.1016/j.bbamem.2011.11.033 ↗
66. Model parameters for simulation of physiological lipids10.1002/jcc.24324 ↗
67. Interaction of vitamin K1 and vitamin K2 with Dimyristoylphosphatidylcholine and their location in the membrane10.1021/acs.langmuir.9b03552 ↗
68. The influence of vitamin K1 on the structure and phase behaviour of model membrane systems10.1016/S0005-2736(99)00034-6 ↗
69. Interaction between alpha-tocopherol and heteroacid phosphatidylcholines with different amounts of unsaturation10.1016/0005-2736(95)00276-6 ↗
70. Diosgenin is an exogenous activator of 1,25D(3)-MARRS/Pdia3/ERp57 and improves Alzheimer’s disease pathologies in 5XFAD mice10.1038/srep00535 ↗
71. Diosgenin-induced cognitive enhancement in normal mice is mediated by 1,25D(3)-MARRS10.1038/srep03395 ↗
72. Curcumin: A Review of Its Effects on Human Health10.3390/foods6100092 ↗